Squamous Cell Carcinoma
Esophageal and cardia adenocarcinoma classification needs readdressing to optimize treatment
Published in Drug Week, June 16th, 2006
According to a recent report, researchers in Sweden conducted a study "to evaluate the diagnostic accuracy of esophageal and cardia adenocarcinoma in the Swedish Cancer Register. Based on cancer registers, a rising incidence of esophageal and cardia adenocarcinoma has been reported in several, but possible influence of differences in tumor classification has not been evaluated. In a nationwide study in 1995 through 1997, all Swedish patients, born in Sweden and younger than 80 years with esophageal or cardia...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2006-06-16)
More Articles from Drug Week
- Cardiology
Acadesine reduces 2-year mortality following heart attacks in heart bypass patients - Drug Development
Acologix presents preclinical data on synthetic peptide - Drug Development
Axonyx completes multiple-dose phase I study of Posiphen - HIV/AIDS Drug Development
HIV-1 CD4 attachment inhibitor inhibits viral entry by altering envelope conformation - Sexual & Reproductive Health
ImQuest: Pyrimidinedione appears to prevent HIV transmission - Addiction Medicine
Bivalent morphine/heroin vaccine prevents relapse to heroin addiction - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
